Don't let guard down: Centre to states amid Covid surge in southeast Asia

Testing for influenza-like illness (ILI) and severe acute respiratory infections (SARI) cases has been the pillars of Covid management for the government.

testing
(Photo: Reuters)
Press Trust Of India
2 min read Last Updated : Mar 19 2022 | 1:00 AM IST
Citing the resurgence of coronavirus cases in southeast Asia and parts of Europe, the Centre has asked the states to restart monitoring influenza-like illness and severe acute respiratory infections so that no early warning signals are missed and Covid is controlled.
 
Testing for influenza-like illness (ILI) and severe acute respiratory infections (SARI) cases has been the pillars of Covid management for the government.
 
However, the testings were stopped recently as India has been recording a steady decline in Covid-19 cases.
As part of intensified surveillance, patients being hospitalised with ILI and SARI will again be tested for Covid-19 and positive samples will be sent for genome sequencing.
 
In a letter, Union Health Secretary Rajesh Bhushan has asked all states and Union Territories to ensure an adequate number of samples are submitted to the INSACOG network for timely detection of new Covid variants.
 
He also stressed on maintaining testing according to protocols, observing all precautions and not letting the guard down while resuming economic and social activities.
 
"Effective surveillance by monitoring of emerging clusters of new cases, if any, testing as per norms and monitoring of ILI and SARI cases shall be taken up on a continued basis to ensure no early warning signals are missed and spread of infection can be controlled,” Bhushan said in the letter.
 
He further said the state machinery should create required awareness and ensure adherence to Covid-appropriate behaviour and practise effective hand and respiratory hygiene.
 
With a spike in Covid-19 cases across Southeast Asia and some countries of Europe, a high-level meeting was chaired by Health Minister Mansukh Mandaviya on March 16 where the states were advised to focus on aggressive genome sequencing, intensified surveillance and overall vigil on the Covid situation, Bhushan said in the letter. He also emphasised continued focus on the five-fold strategy of test, track, treat and vaccination and adherence to Covid-appropriate behaviour.
 
“All the states and Union Territories must observe all precautions and not let the guard down while resuming economic and social activities," Bhushan stated.
 
"It is also vital that states may ensure all eligible people are motivated to get vaccinated against Covid-19 as per the recent expansion of vaccination drive," he added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story